Elevance Health Upgrades Profit Outlook Despite Stock Decline

Elevance Health has revised its annual profit outlook upwards after exceeding earnings expectations in the second quarter. Despite this, the insurer's share price declined over 11%, as investors expected a more significant revision. Analysts highlighted that the increased profit forecast did not align with the earnings beat, leading to a broader selloff across the insurance sector. Notably, shares of Molina, Centene, Oscar, and UnitedHealth also fell by 2% to over 4%.

The company improved its profit forecast by 25 cents per share to a minimum of $27, following a quarterly earnings per share result that exceeded predictions by $1.24. According to Baird analyst Michael Ha, market expectations were high entering this earnings cycle. As the first significant health insurer to release quarterly earnings, Elevance's results set a precedent for UnitedHealth's upcoming report. Jefferies analyst David Windley remarked that, despite positive stock momentum since the last quarter, incremental gains might not meet market expectations.

Elevance faced increased medical expenses due to rising healthcare service utilization among government-funded program members. The insurer has significant exposure to commercial insurance and Medicaid and is withdrawing from underperforming Medicare Advantage markets. For Q2, Elevance reported a medical loss ratio of 89.7%, better than analysts' expectations of 90.15%, according to LSEG data.

Changes in U.S. Medicaid policies are adding pressure on plans as states reassess eligibility. Healthier individuals exiting Medicaid leave a patient pool with higher medical needs. Budget constraints and modifications to work-related Medicaid rules further compound these challenges. CEO Gail Boudreaux stated, "Our Medicaid operating margin outlook remains appropriately prudent and unchanged from our prior guidance." The company plans to exit additional Medicaid markets within 12 to 18 months, where sustained operations are not viable.

Analysts predicted an average annual profit of $26.86 per share, based on LSEG data. Elevance's quarterly adjusted profit per share reached $7.45, surpassing the expected $6.21. The insurer targets at least 12% adjusted profit growth by 2027.